AMA Concert Genetics New Test ID Tool Works to Improve Reimbursement Process Premium The company previously launched its Concert Coding Engine to help standardize how genetic tests are coded and how labs can bill for them. AMA Quickly Issuing New Proprietary Analyses Codes, but Will They Improve MDx Reimbursement? Premium Since last year the AMA has issued 23 PLA codes for firms that want to better track use of their tests, but the effect of the codes on improving reimbursement remains to be seen. NGS Test Coding Changes Slated for Discussion at 2017 CPT Editorial Panel Meeting The panel's decisions could change the codes diagnostic companies use to bill payors for these tests, which could affect revenue. Amid PAMA Implementation, Stakeholders Contemplate Coding to Facilitate Market-Based MDx Pricing Premium The coding requirements will be a particularly complicated aspect of implementing the new law which aims to move diagnostic pricing to a market-based system. Amid Competing LDT Regulatory Proposals, Common Ground but Key Disagreements for Congress to Consider Premium Multiple legislative proposals before Congress show regulation of lab-developed tests remains divisive within the life sciences community. Nov 18, 2014 Lab Group Hires Lawyers to Parry FDA Regulation; AMA-led Groups Push for Rulemaking Oct 15, 2014 CMS Issues Preliminary Lab Fee Schedule Determinations for Genomic Testing CPT Codes Premium Oct 2, 2013 CMS National Payment Limit for Tier 1 Codes Not as Low as Before, but Challenges Remain Premium May 22, 2013 CMS Issues Pricing for MDx Codes; Labs, Test Developers Still Critical of Rates and Methodology Premium Mar 20, 2013 AMP Submits Proposal to AMA Covering CPT Codes for Sequencing-based Assays Mar 6, 2013 In Unexpected Collaboration, AMA, McKesson Partner to Clarify Molecular Diagnostic Claims Coding Premium Feb 26, 2013 McKesson, AMA Developing Reference Product for MDx Jan 30, 2013 Palmetto Loses Appeal to Remain JE CMS Contractor, but May Continue Running MolDx Premium Jan 17, 2013 NIH Genetic Test Registry to Integrate AMA's CPT Codes Oct 3, 2012 Industry-Backed Bill Introduced in House as Frustration Grows over CMS Payment Process for MDx Premium Sep 19, 2012 CMS Stance on Reimbursement of Multi-Analyte Algorithm Assays Raises Industry Concerns Premium Jul 18, 2012 Lab Industry, Pathologists Still at Odds Over Fee Schedule for New Molecular Pathology CPT Codes Premium May 30, 2012 AMP Aims for June Release of Draft CPT Codes for NGS-Based Dx Tests Premium Apr 18, 2012 Harvard Pilgrim, Trustmark Join Other Payors Considering Outsourcing MDx Claims to Specialty Vendors Premium Mar 9, 2012 Vermillion Receives CPT Code for OVA1 Premium Mar 7, 2012 AMA Approves Vermillion MAAA Category 1 Code for OVA1; Will it Improve Reimbursement? Premium Mar 6, 2012 Vermillion's OVA1 Test Assigned Category 1 CPT Code; Stock Jumps Feb 29, 2012 Palmetto's Jeter Discusses Efforts to Advance Value-Based Reimbursement System for MDx Premium Feb 29, 2012 European Researchers and Pharmas Launch Effort to Link Gene Markers to Diabetes, Personalize Drugs Premium Jan 11, 2012 CAP Urges CMS to Publish Recommended Payment Values for Molecular Dx CPT Codes Premium Load More Breaking News Centogene Strikes Rare Disease Target Discovery Deal With Insilico Medicine Dilated Cardiomyopathy Gene Mutations Point to Possible Therapeutic Strategy Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Parse Biosciences Partners With Research Instruments for Southeast Asia Distribution Thermo Fisher, Oncocyte Ink Development, Comarketing Deal for Cancer IVDs The Scan And a Fourth? A fourth dose of the Pfizer-BioNTech SARS-CoV-2 vaccine in an Israeli study increased antibody levels but did not prevent Omicron variant infections, according to the Financial Times. For Better Science Software A virtual institute funded by former Google CEO Eric Schmidt's philanthropy aims to lure software engineers to academia, Science reports. Recommendation Explanations The New York Times writes that the US Centers for Disease Control and Prevention is straining to both make and explain decisions based on limited information. Genome Research Papers on De Novo Mutation Rates, Polyploid Genotyping, Oncogene Epigenomic Translocation In Genome Research this week: de novo mutations rates in hemoglobin subunits, analysis of variant calling methods for polyploid plants, and more.